Sloning to Synthesize Genes Using Automated Technology | GenomeWeb
NEW YORK (GenomeWeb News) - Sloning Biotechnology has entered the synthetic gene-production market this month with an automated process, the company said today.
 
The company's technology, named Slonomics, will use a library of universal double-stranded DNA building blocks that the company will assemble with industrial robotic machines.
 
Additional details were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.